Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure
Condition(s):Acute Heart FailureLast Updated:October 31, 2018Withdrawn
Hide Studies Not Open or Pending
Condition(s):Acute Heart FailureLast Updated:October 31, 2018Withdrawn
Condition(s):Heart FailureLast Updated:November 22, 2023Completed
Condition(s):Acute Decompensated Heart FailureLast Updated:December 5, 2016Terminated
Condition(s):HealthyLast Updated:October 24, 2023Completed
Condition(s):Heart FailureLast Updated:November 26, 2021Completed
Condition(s):CardiomyopathyLast Updated:February 16, 2023Completed
Condition(s):End Stage Renal Disease on DialysisLast Updated:March 5, 2024Suspended
Condition(s):Acute Heart Failure; Acute Kidney InjuryLast Updated:August 18, 2020Unknown status
Condition(s):Liver CirrhosisLast Updated:February 14, 2024Recruiting
Condition(s):Healthy ParticipantsLast Updated:April 27, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.